Aug-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
My Blue Dove has shown varied performance across different states and product categories over recent months. In California, the brand has maintained a steady presence in the Tincture & Sublingual category, holding the 10th position in both May and June 2024. However, there was a noticeable drop in July and August 2024, where the brand slipped to the 17th rank. This decline might indicate increased competition or shifting consumer preferences. Despite the drop in ranking, the brand's sales figures showed a slight increase from May to June, before experiencing a significant dip in July, followed by a minor recovery in August. This fluctuation in sales could suggest a need for strategic adjustments to regain market share.
In other states and categories, My Blue Dove's performance has been less prominent, as the brand did not make it into the top 30 rankings. This absence could be interpreted as a challenge in gaining traction or market penetration outside of California. The brand's ability to maintain a top 10 position in California's Tincture & Sublingual category for two consecutive months highlights its established presence in that market, but the drop in subsequent months raises questions about sustainability and growth potential. Monitoring these trends and understanding the underlying factors will be crucial for My Blue Dove to enhance its market position and expand its footprint in other states and categories.
Competitive Landscape
In the California Tincture & Sublingual category, My Blue Dove has experienced notable fluctuations in its rank over the past few months. Starting strong in May and June 2024 with a consistent 10th place, the brand saw a decline to 17th place in both July and August 2024. This drop in rank is significant when compared to competitors like Dr. May, which maintained a steady position around 15th place, and Moods Spray, which improved from 16th to 14th place over the same period. Additionally, High Gorgeous by Yummi Karma re-entered the top 20 in August 2024, which could indicate increasing competition. Despite these shifts, My Blue Dove's sales figures have shown resilience, with a noticeable rebound in August 2024. This dynamic landscape suggests that while My Blue Dove faces stiff competition, there are opportunities for strategic adjustments to regain and potentially improve its market position.
Notable Products
In August 2024, the top-performing product for My Blue Dove was High THC Full Spectrum Oil (1g) in the Concentrates category, which rose from the third position in July to the first, achieving sales of 1176 units. Sativa Tincture (1000mg THC, 30ml) maintained its second position from July, with sales increasing to 763 units. Indica Tincture (1000mg THC, 30ml) dropped from first in July to third in August, showing a slight decrease in sales to 754 units. CBD MCT Tincture (500mg CBD, 30ml, 1oz) remained steady in the fourth position with sales climbing to 660 units. Hybrid Tincture (1000mg THC, 30ml) re-entered the rankings in fifth place after not being listed in June and July, with sales reaching 539 units.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.